Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ODEVIXIBAT vs OLANZAPINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ODEVIXIBAT vs OLANZAPINE: Safety Overview

Metric ODEVIXIBAT OLANZAPINE
Total FAERS Reports 223 51,444
Deaths Reported 10 5,535
Death Rate 4.5% 10.8%
Hospitalizations 43 21,934
Average Patient Age 14.3 yrs 44.3 yrs
% Female Patients 49.4% 46.1%
FDA Approval Date Jul 20, 2021 Apr 23, 2012
Manufacturer Albireo Pharma, Inc. REMEDYREPACK INC.
Route ORAL ORAL
Marketing Status Prescription Prescription